SureTrader Advertisement Advertisement
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
Followed By 1,172
Posts 143,448
Boards Moderated 8
Alias Born 01/25/09
160x600 placeholder
PharmaCyte Biotech Provides Link to Orphan Drug Designation for Its Pancreatic Cancer Treatment "GlobeNewswire Inc." - 11/24/2015 9:25:00 AM
PharmaCyte Biotech Announces Appointment of International Diabetes Expert to Scientific Advisory Board "GlobeNewswire Inc." - 11/19/2015 10:41:11 AM
PharmaCyte Biotech Appoints International Diabetes Expert to Its Scientific Advisory Board "GlobeNewswire Inc." - 11/19/2015 9:25:00 AM
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment "GlobeNewswire Inc." - 11/17/2015 9:22:24 AM
PharmaCyte Biotech Scientific Advisory Board Member Named Clinical Director of Prestigious Boston Cancer Center "GlobeNewswire Inc." - 11/10/2015 10:18:08 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/2/2015 4:15:41 PM
PharmaCyte Biotech Hosts 2nd Annual Meeting of International Diabetes Consortium Developing Novel Treatment for Diabetes "GlobeNewswire Inc." - 10/29/2015 9:20:00 AM
PharmaCyte Biotech Management Interviewed to Discuss Key Aspects of New Pancreatic Cancer Clinical Trial Design "GlobeNewswire Inc." - 10/23/2015 9:20:00 AM
PharmaCyte Biotech Clinical Trial Designed to Expand Standard of Care Therapy for Pancreatic Cancer "GlobeNewswire Inc." - 10/21/2015 9:20:00 AM
PharmaCyte Biotech to Conduct Pancreatic Cancer Clinical Trial in United States "GlobeNewswire Inc." - 10/19/2015 9:49:14 AM
PharmaCyte Biotech Aims for Consolidated Therapy to Address Unmet Medical Need in Upcoming Cancer Clinical Trial "Marketwired" - 10/15/2015 9:25:00 AM
PharmaCyte Biotech Designs Clinical Trial to Meet Critical Unmet Medical Need "GlobeNewswire Inc." - 10/14/2015 9:25:00 AM
Armed With FDA Orphan Drug Status in the U.S., PharmaCyte Biotech Now Securing Europe for Pancreatic Cancer Treatment "Marketwired" - 10/9/2015 9:25:00 AM
PharmaCyte Biotech CEO in Europe to Secure Orphan Designation With the EMA "GlobeNewswire Inc." - 10/7/2015 9:25:00 AM
Imaging Endpoints Founder Discusses Role in PharmaCyte Biotech’s Unique Approach to Pancreatic Cancer for Upcoming Clinical... "GlobeNewswire Inc." - 10/5/2015 9:25:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/2/2015 5:01:55 PM
PharmaCyte Biotech Retains Industry Expert to Monitor Short Sellers and Market Makers "GlobeNewswire Inc." - 10/1/2015 9:25:00 AM
PharmaCyte Biotech’s Encapsulation Technology Could Address Unmet Medical Need "GlobeNewswire Inc." - 9/28/2015 9:25:00 AM
PharmaCyte Biotech Hires Industry-Leading Firm to Assist With Investigational New Drug Application "GlobeNewswire Inc." - 9/25/2015 9:25:00 AM
PharmaCyte Biotech Discusses Pancreatic Cancer Treatment for Upcoming Phase 2b Human Clinical Trial "GlobeNewswire Inc." - 9/22/2015 10:42:27 AM
If Only Steve Jobs Had Known PharmaCyte Biotech & Cell-in-a-Box "InvestorsHub NewsWire" - 9/17/2015 8:30:00 AM
PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer "GlobeNewswire Inc." - 9/15/2015 9:30:00 AM
PharmaCyte Biotech Begins Phase 2b Clinical Trial Push With Imaging Endpoints Contract for Radiological Imaging "GlobeNewswire Inc." - 9/9/2015 9:30:00 AM
PharmaCyte Biotech Executives Interviewed on Role of Leaders in Oncology for Development of Its Clinical Trials "GlobeNewswire Inc." - 9/2/2015 9:00:00 AM
PharmaCyte Biotech Announces Successful Completion of Interim Audit of GMP Facility for the Production of Cell-in-a-Box for C... "GlobeNewswire Inc." - 8/25/2015 9:38:50 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist